Fundz

Diamante Closes Euro 595,000 Seed Round Led By Arieli Capital

PRIVATEJan 17, 2023

Round Type

Seed

BiotechnologyHealth CareTherapeutics

Investors

Angels4 WomenElena Paola LanatiDiamanteArieli Capital

Description

Diamante S.r.l., a female-led Italian biotechnology company focused on the use of plants for producing high value-added molecules, closes Euro 595K as a second Seed Round led by Arieli Capital. Offering value for global markets, Diamante is creating a groundbreaking health technology with the power to improve the health of millions of people around the world.

Quick answer

Diamante Srl raised an undisclosed amount in a Seed round, dated January 17, 2023. Investors: Angels4 Women, Elena Paola Lanati, Diamante and Arieli Capital.

How much did Diamante Srl raise?
Diamante Srl raised an undisclosed amount in a Seed round on January 17, 2023.
Who invested in Diamante Srl?
Angels4 Women, Elena Paola Lanati, Diamante and Arieli Capital are named as investors in this round.
What does Diamante Srl do?
DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Diamante Srl that raised within 45 days of this round, from Fundz verified event records.

  • GenoME Diagnostics raised $1.8M (Seed) on March 3, 2023.
  • Chroma Medicine raised $135M (Series B) on March 1, 2023.
  • Wilson Wolf Manufacturing raised an undisclosed amount on March 1, 2023.
  • Aprea Therapeutics raised an undisclosed amount (Funding Round) on February 28, 2023.
  • Tessera Defense & Homeland Security Inc. raised $1.5M (Seed) on February 27, 2023.
  • Transcend Therapeutics raised an undisclosed amount (Series A) on February 23, 2023.

Who to call at Diamante Srl, and when

A new round usually means Diamante Srl is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Diamante Srl raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Diamante Srl, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Diamante Srl. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Diamante Srl

About

DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules. The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications. As an innovation-oriented female company, our value proposition is the creation of novel therapeutic approach for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides. Diamante, thanks to the Regione Veneto and particularly though the national grant POR FESR AZIONE 1.1.1 2020/2021, has achieved important results in the diagnostic field for the Rheumatoid Arthritis (RA). This project allowed the company to increase the team with two more specialized people and to develop a specific technology platform for the RA diagnoses.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Diamante Srl raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Diamante Srl's next move

See what Strategic adds

Diamante Srl raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.